
96 articles

A new targeted therapy shows promise against aggressive childhood and adult cancers, marking a significant step forward…

New research from April 23, 2026, reveals ADHD treatment is safe for patients with a history of psychosis, showing no in…

A major cancer vaccine breakthrough extends survival for patients, detailed on April 23, 2026, marking a significant shi…

Labcorp’s FDA-approved companion diagnostic for ovarian cancer patients eligible for KEYTRUDA® marks a significant advan…

Merck’s novel combo pill Idvynso receives FDA approval, amplifying its presence in the HIV treatment market and offering…

A new Tufts Now study reveals the FDA ‘Healthy’ label significantly impacts consumer snack choices and willingness to pa…

Keck School of Medicine of USC researchers have identified a new treatment target for fatal infant heart disease, offeri…

CEPI and Pasteur Network partner to advance regional vaccine R&D and outbreak preparedness, strengthening global health…

British Columbia marks 10 years since declaring a toxic drug public health emergency, highlighting the ongoing danger of…

The NFID confirms the vaccine trial gold standard is a long-standing practice, not new, reinforcing trust in vaccine saf…

An FDA-approved cancer drug may treat drug-resistant herpes, offering new hope for millions. This groundbreaking discove…